Lisata Therapeutics Stock Analysis

Lisata Stock Analysis Notes

About 19.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.71. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Lisata Therapeutics recorded a loss per share of 2.51. The entity had not issued any dividends in recent years. The firm had 1:15 split on the 15th of September 2022. Lisata Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing cellular therapies to reverse disease andor promote the regeneration of damaged tissue. Lisata Therapeutics, Inc. was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey. Lisata Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 27 people. To find out more about Lisata Therapeutics contact BSc B at 908 842 0100 or learn more at https://www.lisata.com.

Lisata Therapeutics Investment Alerts

Lisata Therapeutics Upcoming and Recent Events

Lisata Largest EPS Surprises

View All Earnings Estimates

Lisata Therapeutics Environmental, Social, and Governance (ESG) Scores

Lisata Stock Institutional Investors

Note, although Lisata Therapeutics' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Lisata Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 23.84 M.

Lisata Profitablity

Management Efficiency

Lisata Therapeutics has return on total asset (ROA) of (0.2872) % which means that it has lost $0.2872 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.4403) %, meaning that it created substantial loss on money invested by shareholders. Lisata Therapeutics' management efficiency ratios could be used to measure how well Lisata Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities. As of November 27, 2024, Return On Tangible Assets is expected to decline to -0.4. In addition to that, Return On Capital Employed is expected to decline to -0.56. At present, Lisata Therapeutics' Total Current Assets are projected to increase significantly based on the last few years of reporting. The current year's Other Assets is expected to grow to about 1.5 M, whereas Total Assets are forecasted to decline to about 43.4 M.

Technical Drivers

As of the 27th of November, Lisata Therapeutics secures the Risk Adjusted Performance of 0.0224, mean deviation of 2.51, and Downside Deviation of 3.28. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Lisata Therapeutics, as well as the relationship between them.

Lisata Therapeutics Price Movement Analysis

Lisata Therapeutics Insider Trading Activities

Lisata Therapeutics Predictive Daily Indicators

Lisata Therapeutics Corporate Filings

Lisata Therapeutics Forecast Models

Lisata Therapeutics' time-series forecasting models are one of many Lisata Therapeutics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Lisata Therapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Lisata Therapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Lisata shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Lisata Therapeutics. By using and applying Lisata Stock analysis, traders can create a robust methodology for identifying Lisata entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Lisata analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Lisata analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Lisata Therapeutics stock analysis indicators help investors evaluate how Lisata Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Lisata Therapeutics shares will generate the highest return on investment. By understating and applying Lisata Therapeutics stock analysis, traders can identify Lisata Therapeutics position entry and exit signals to maximize returns.

When running Lisata Therapeutics' price analysis, check to measure Lisata Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lisata Therapeutics is operating at the current time. Most of Lisata Therapeutics' value examination focuses on studying past and present price action to predict the probability of Lisata Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lisata Therapeutics' price. Additionally, you may evaluate how the addition of Lisata Therapeutics to your portfolios can decrease your overall portfolio volatility.